OpenAI Releases GPT-5.5, a Fully Retrained Agentic Model That Scores 82.7% on Terminal-Bench 2.0 and 84.9% on GDPval ...
In 2015, AI in drug discovery was still a theoretical pursuit – exciting, but unproven. A few early start-ups were applying deep learning to virtual screening and molecular modelling, but the industry ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results